Loading organizations...
Loading organizations...
Novel cancer therapies using engineered proteins to target tumor cells.
PolyProx has raised $5.7M across 2 funding rounds.
PolyProx has raised $5.7M in total across 2 funding rounds.
PolyProx has raised $5.7M in total across 2 funding rounds.
PolyProx's investors include Enrique Millan, Cambridge Enterprise, Cambridge Innovation Capital, RT Capital, Christine Martin, Sohaib Mir.
PolyProx has raised $5.7M across 2 funding rounds. Most recently, it raised $1.3M Seed in March 2020.
| Date | Round | Lead Investors | Other Investors |
|---|---|---|---|
| Mar 2, 2020 | $1.3M Seed | Enrique Millan | Cambridge Enterprise, Cambridge Innovation Capital, RT Capital |
| Apr 30, 2019 | $4.4M Seed | Christine Martin, Sohaib Mir, RT Capital |